You're signed outSign in or to get full access.
Ally Bridge Group (ny) LLC
Ally Bridge Group is a global healthcare investment management firm, investing across the full capital structure in high-impact life sciences innovation through both private and public equity strategies.
Investment Strategy
Invests across the healthcare industry in both private equity and public equity; seeks opportunities in high-impact life science innovation, leveraging global knowledge and local talent.
Latest 13F Filing Activity
Ally Bridge Group (ny) LLC filed their most recent 13F report on Jun 30, 2025 disclosing 21 equity positions with a total 13F market value of $120M. The fund increased holdings in Lenz Therapeutics Inc., Soleno Therapeutics Inc., Verona Pharma PLC among other positions. Ally Bridge Group (ny) LLC reduced exposure to Springworks Therapeutics Inc., Axsome Therapeutics Inc., Blueprint Medicines Corp. among others.
Top Holdings
Equity Positions (21)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
V VRNA | VERONA PHARMA PLC | 12.65% | $15.2M | 160,701 | $67.68 | $94.58 | +$6.4M |
S SLNO | SOLENO THERAPEUTICS INC | 12.47% | $15.0M | 178,819 | $62.49 | $83.78 | +$6.4M |
L LENZ | LENZ THERAPEUTICS INC | 8.37% | $10.1M | 343,322 | $29.31 | $29.31 | +$10.1M |
M MRUS | MERUS N V | 6.14% | $7.4M | 140,208 | $37.43 | $52.60 | +$4.1M |
E ELVN | ENLIVEN THERAPEUTICS INC | 4.70% | $5.6M | 281,394 | $22.78 | $20.06 | +$2.3M |
Industry Allocation
Investment Team (9)
| Name | Role | Location | |
|---|---|---|---|
 | Principal | San Francisco, CA , United States | |
 | Senior Analyst | New York, NY , United States | |
 | President and Portfolio Manager, Public Equity | Miami, FL , United States | |
S Srishti Kotiyal | Private Equity Associate | New York, NY , United States | |
S Stephen Mallon | Analyst | New York, NY , United States | |
T Tian Sun | Research Analyst | New York, NY , United States | |
E Emily Tai | Analyst | New York, NY , United States | |
P Paresh Kumar | Vice President, Biotech Private Equity | Boston, MA , United States | |
 | Senior Associate | New York, NY , United States |
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more